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Abstract
Introduction: Insecticide-treated nets (ITNs) are one of the main interventions used for malaria control. However, these nets
may also be effective against other vector borne diseases (VBDs). We conducted a systematic review and meta-analysis to
estimate the efficacy of ITNs, insecticide-treated curtains (ITCs) and insecticide-treated house screening (ITS) against Chagas
disease, cutaneous and visceral leishmaniasis, dengue, human African trypanosomiasis, Japanese encephalitis, lymphatic
filariasis and onchocerciasis.
Methods: MEDLINE, EMBASE, LILACS and Tropical Disease Bulletin databases were searched using intervention, vector- and
disease-specific search terms. Cluster or individually randomised controlled trials, non-randomised trials with pre- and post-
intervention data and rotational design studies were included. Analysis assessed the efficacy of ITNs, ITCs or ITS versus no
intervention. Meta-analysis of clinical data was performed and percentage reduction in vector density calculated.
Results: Twenty-one studies were identified which met the inclusion criteria. Meta-analysis of clinical data could only be
performed for four cutaneous leishmaniasis studies which together showed a protective efficacy of ITNs of 77% (95%CI:
39%–91%). Studies of ITC and ITS against cutaneous leishmaniasis also reported significant reductions in disease incidence.
Single studies reported a high protective efficacy of ITS against dengue and ITNs against Japanese encephalitis. No studies
of Chagas disease, human African trypanosomiasis or onchocerciasis were identified.
Conclusion: There are likely to be considerable collateral benefits of ITN roll out on cutaneous leishmaniasis where this
disease is co-endemic with malaria. Due to the low number of studies identified, issues with reporting of entomological
outcomes, and few studies reporting clinical outcomes, it is difficult to make strong conclusions on the effect of ITNs, ITCs or
ITS on other VBDs and therefore further studies be conducted. Nonetheless, it is clear that insecticide-treated materials such
as ITNs have the potential to reduce pathogen transmission and morbidity from VBDs where vectors enter houses.
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Introduction
The World Health Organisation (WHO) promotes the use of
Integrated Vector Management (IVM) to control vector borne
diseases (VBDs) [1]. Briefly, IVM involves the use of a range of
proven vector control tools used either alone or in combination
selected based on knowledge of the local vector ecology and
epidemiological situation. IVM can involve use of multiple vector
control tools against a single disease or alternatively a single tool
against multiple diseases. This is particularly the case where vector
control interventions are active against more than one disease and
VBDs overlap in their distribution.
IVM is a WHO policy for effective, cost effective and
sustainable vector control. In order to exploit synergies between
VBDs and make vector control more cost effective, IVM advocates
for the use of shared interventions across diseases. However, in
order to be able to do this it is important to first know whether
interventions are effective against multiple diseases. This was the
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rationale for conducting this review. We considered insecticide-
treated bednets (ITNs) since this intervention has been rolled out
already on a large scale for malaria vector control.
ITNs form the mainstay of malaria vector control in many
malaria endemic areas [2]. ITNs are estimated to reduce all-cause
child mortality by 17% and uncomplicated Plasmodium falci-
parum episodes in areas of stable transmission by 50%, compared
to no nets [3]. ITNs have been rolled out in malaria-endemic
regions on a large scale, particularly in sub-Saharan Africa (SSA).
Between 2004 and 2010, the number of ITNs delivered by
manufacturers to malaria endemic countries in SSA increased
from 6 million to 145 million [2]. The percentage of households
owning at least one ITN in SSA is estimated to have risen from 3%
in 2000 to 56% in 2012, but declined slightly to 54% in 2013.
More work is needed to reach ITN coverage targets set by Roll
Back Malaria of 80% use of ITNs by individuals in populations at
risk [4]. Outside Africa, 60 million ITNs were distributed during
2009–2012, with 10 countries accounting for 75% of the total
(India 9.2 million, Indonesia 6.1 million, Myanmar 5.4 million,
Bangladesh 4.7 million, Afghanistan 4.3 million, Cambodia 3.6
million, Papua New Guinea 3.2 million, Haiti 3.0 million and
Philippines 3.0 million) [2]. More recently conventional ITNs have
been replaced by long lasting insecticide-treated nets (LLINs) that
maintain effective levels of insecticide for at least three years
meaning that re-treatment with insecticide is not necessary. Since
2007 the WHO recommends only use of LLINs and not
conventional ITNs [5]. For the purpose of this review we refer
to ITNs without distinguishing between conventional ITNs or
LLINs.
ITNs are likely to be effective against multiple vectors and
VBDs since a substantial proportion of transmission occurs
indoors, but this has not been systematically assessed. As such
there may be unknown collateral benefits of ITN roll-out on VBDs
in addition to malaria. ITNs as well as insecticide-treated curtains
(ITC) and insecticide-treated screening are likely to function in the
same way. Disease vectors are attracted to host odours emanating
either from people sleeping under ITNs or from people within
houses in the case of ITCs and ITS. Vectors then coming into
contact with these materials are deterred or killed and thus it can
be said that the ITN and house are acting as ‘baited traps’. ITC
and ITS may also be working to some extent to prevent vectors
from entering houses (household level protection) rather than
personal protection in the case of ITNs.
We conducted a systematic review to assess the efficacy of ITNs,
ITCs or ITS against eight VBDs prioritised by the WHO in the
Handbook for IVM [6]: Chagas disease, cutaneous and visceral
leishmaniasis, dengue, human African trypanosomiasis, Japanese
encephalitis, lymphatic filariasis and onchocerciasis. In this study
we assessed the effect of ITNs, ITCs and ITS on clinical and
entomological outcomes.
Methods
Literature search
The review was carried out according to a protocol and
analytical plan that was prepared in advance. A systematic search
of published literature was performed in April 2013 and repeated
in June 2014 using intervention-specific search terms (for example
ITN/LLIN/bednet/curtain/pyrethrins), as well as vector and
disease specific search terms. MeSH and DeCS terms were used
where appropriate. More detail on the search terms used is given
in Supporting Information S1. MEDLINE (1950 -), EMBASE
(1980 -) and LILACS (1982 -) databases were searched and no
language restrictions were applied. In April 2013 we also searched
the Tropical Disease Bulletin (1912 -) database. In addition, we
reviewed the reference lists of key review articles and consulted
with experts to identify further studies.
The search was conducted as part of a larger systematic review
on all types of vector control interventions against eight different
VBDs [6]: Chagas disease, cutaneous and visceral leishmaniasis,
dengue, human African trypanosomiasis, Japanese encephalitis,
lymphatic filariasis and onchocerciasis.
AW screened the search results for potentially relevant studies
and full text documents were obtained for those publications
deemed to be relevant. Foreign language studies were evaluated by
a native speaker in consultation with AW. The articles were
scrutinised to ensure that multiple publications from the same
study were included only once.
Study inclusion and exclusion criteria
Studies were assessed against inclusion and exclusion criteria by
AW and SL independently. Studies were included if they
compared the efficacy of ITNs, ITCs or ITS versus no
intervention (control group) in disease endemic areas. Excluded
studies and reasons for their exclusion are detailed in Supporting
Information S2. We sought to compare the efficacy of ITNs, ITCs
and ITS versus no intervention, rather than assess the efficacy of
untreated bednets, curtains or screening or compare these
untreated materials to ITNs, ITCs or ITS. We took this decision
because bednets being rolled out for malaria control are
insecticide-treated. Studies using hand-impregnated nets or factory
manufactured LLINs were included. Studies assessed the effect of
the intervention on either i) clinical outcomes (incidence or
prevalence of disease or infection – whether this was confirmed by
the patient, clinical diagnosis or diagnostically differed by study)
and/or ii) entomological outcomes (including human biting rate,
adult vector density and Stegomyia indices, pupal/demographic
indices, oviposition rates or ovitrap positivity for dengue vectors).
Adult vector density was measured using a number of techniques
including Centers for Disease Control (CDC) light traps, sticky
traps, pyrethrum spray catches and resting catches using
aspirators. Larval indices extracted for dengue were house index
(percentage of houses infested with larvae and/or pupae),
container index (percentage of water containers infested with
active immatures) and Breteau index (number of positive
Author Summary
Malaria is a deadly disease caused by a parasite which is
transmitted by anopheline mosquitoes. Bednets treated
with insecticide are one of the key tools used to prevent
malaria and they have been distributed on a large scale in
many countries, particularly in Africa. It may be possible to
control other diseases transmitted by insects using
insecticide-treated bednets because many of these insects
also enter houses. We did a review of studies looking at
the effectiveness of insecticide-treated bednets, curtains
and house screening against nine major diseases trans-
mitted by insects. We assessed the effect these tools had
on reducing numbers of the insects and disease in
humans. Insecticide-treated bednets were found to be
effective in preventing cutaneous leishmaniasis—a disease
transmitted by sandflies—and insecticide-treated curtains
and screening showed potential in preventing other insect
borne diseases. Although further studies are required, it is
clear that insecticide-treated bednets, curtains and screen-
ing have the potential to prevent transmission of insect-
transmitted diseases.
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containers per 100 houses). We also extracted data on pupae per
person (number of pupae collected over the total number of
inhabitants of the households inspected), oviposition rates (mean
number of Aedes aegypti eggs per trap) and ovitrap positivity
(percentage of traps positive for Aedes eggs).
In terms of study designs, we included i) randomised controlled
trials (cluster level or individual randomisation), ii) non-rando-
mised trials with pre- and post-intervention data (for both control
and intervention areas) and iii) rotational studies (provided there
was baseline data or allocation was random or interventions/
collectors were rotated appropriately e.g. each house received each
intervention). A rotational design is when an intervention(s) is
moved between sampling sites for set time periods or, in the case of
human landing catches, collectors are rotated between interven-
tions.
Studies performed under laboratory or semi-field conditions (for
example, experimental huts) were excluded. We also excluded
non-randomised trials without baseline data (for both control and
intervention areas), non-controlled programme evaluations and
observational studies in which clusters or individuals were not
purposely allocated to intervention and control groups.
Data extraction and analysis
AW (or a third party contractor) extracted data from the
publications into a pre-designed data extraction form in Microsoft
Word (Supporting Information S3), along with data tables and
graphs. Graphs were digitised using Engauge Digitizer software
(version 5.1, http://digitizer.sourceforge.net/). Preliminary anal-
ysis of data tables was conducted in Microsoft Excel. Analysis
assessed the efficacy of ITNs, ITCs or ITS compared to no
intervention. We used un-adjusted measures (clinical and ento-
mological) throughout. This was for consistency because different
studies adjust for different covariates. However, adjusted values,
where available are reported for comparison.
Clinical outcomes were reported as either risks or rates of
disease or infection in the published papers. Meta-analysis of
clinical data (unadjusted risk of disease or infection) was performed
in Stata 13 using the metan command (StataCorp, Texas, U.S.A.).
Pre-intervention risk ratios were plotted on forest plots alongside
post-intervention risk ratios to show comparability of groups at
baseline. Statistical heterogeneity was assessed using a x2 test. Due
to the small number of studies in each comparison, we deemed
there to be heterogeneity if the x2 test p value was less than 0.1 [7].
If heterogeneity was found, a summary effect measure was
calculated using random effect meta-analysis rather than fixed
effect meta-analysis. Protective efficacy (PE) was calculated as
PE= 12(risk ratio of clinical disease or infection during the
intervention period)6100%. PE (or relative risk reduction) can be
interpreted as the percentage reduction in risk of clinical disease or
infection associated with the intervention. Standard formulas were
used to calculate 95% confidence intervals for risk or rate ratios
[8].
Entomological outcomes are reported as means with 95%
confidence intervals, where these are reported in the published
paper or could be calculated. If there were zero events then we
estimated the upper 95% confidence interval as 100 x (3.7/N)
where N is the sample size [9]. For entomological outcomes, where
data were available for multiple intervention and control sites, we
took the average values of the outcome measure, applying equal
weight to all sites. A similar approach was taken if data were
available for multiple timepoints within a year or transmission
season, either pre- or post- intervention. We could not use meta-
analysis to analyse the entomological data due to inadequate
reporting in the published manuscripts. In almost all the studies
the standard error for mean vector density was not reported and
could not be calculated from the data presented in the papers. For
studies with baseline/post intervention data for control and
intervention sites we calculated the percentage reduction in vector
density using a difference in differences approach. We estimated
the effect of the intervention (J) using the formula J = (q1/q0)/
(p1/p0), where q1 and q0 are, respectively, the entomological
indicators (mean density, or biting rate) observed in the
intervention and control areas post-intervention respectively and
p1 and p0 are the corresponding baseline estimates of these
entomological indicators [10]. We calculated the percentage
reduction in entomological indicators as 100 x (1 - J). For studies
in which only post intervention data were available we calculated
the percent reduction in the outcome in the treatment group
compared to the control group using the formula 100 x (1-(q1/q0)
[10]. We were not able to calculate confidence intervals around
percentage reductions due to heterogeneity in study designs; e.g.
different follow up periods pre- and post-intervention and the way
in which the data was reported e.g. the total vector count was
reported rather than individual observations.
We followed recommendations made by the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses (PRISMA)
group where possible [11,12] (Supporting Information S4:
PRISMA checklist).
Risk of bias and study quality assessment
AW and SL assessed independently the risk of bias in the
included studies using a risk of bias assessment form. This form
was developed for the purposes of this review to assess
entomological studies and was adapted from the Effective Practice
and Organisation of Care (EPOC) risk of bias assessment form
[13] (Supporting Information S5). A judgement of high, low or
unclear risk of bias was given for a number of parameters. An
overall bias assessment (high/medium/low) was made based on
the modal bias risk.
We developed a tool for assessing study quality which primarily
concerns the study design and downgrades the score given to the
study depending on whether sample size calculations were
performed (overall and for entomological sampling), the length
of the follow up period and risk of bias (Supporting Information
S6). This was loosely based on the Grading of Recommendations
Assessment, Development and Evaluation (GRADE) system of
rating quality of evidence [14], but adapted for entomological
studies. For the purposes of the quality assessment, we deemed a
trial to be a randomised controlled trial if the published paper
stated that groups were randomised to intervention or control,
even if the process of sequence generation was not described in the
paper.
Results
Summary of studies identified and risk of bias and quality
assessment
The initial systematic literature search identified 19,113 unique
records (Figure 1). 18,617 records were excluded based on review
of the title and abstract. 496 full text records were reviewed and of
these 310 studies met the inclusion/exclusion criteria across all
types of vector control intervention. The update of the search in
June 2014 identified 1,991 unique records, of which 125 full-text
records were reviewed and 2 studies met the inclusion/exclusion
criteria. In total, 21 studies assessed the efficacy of ITNs, ITCs or
ITS versus no intervention and the split of these by disease was
nine cutaneous leishmaniasis, five dengue, one Japanese enceph-
alitis, three lymphatic filariasis and three visceral leishmaniasis.
Insecticide-Treated Materials against Vector Borne Diseases
PLOS Neglected Tropical Diseases | www.plosntds.org 3 October 2014 | Volume 8 | Issue 10 | e3228
Summary tables of the studies identified are given in Supporting
Information S7. Only nine of the 21 studies included reported the
level of insecticide resistance in the study area or conducted an
insecticide bioassay. Of the 21 studies identified, fifteen were
deemed to be at low risk of bias, three at medium risk and three at
high risk of bias [15] (Supporting Information S8). Twelve studies
were deemed to be of high quality, three medium quality and six
low quality (Supporting Information S9). No studies that met the
inclusion and exclusion criteria were found assessing the efficacy of
ITNs, ITCs or ITS against Chagas disease, human African
trypanosomiasis or onchocerciasis.
Efficacy of ITNs and ITCs against cutaneous leishmaniasis
A total of six studies assessing the efficacy of ITNs against
cutaneous leishmaniasis were identified [15–20]. Of these three
reported clinical data only, one reported entomological data only,
and two reported both clinical and entomological data. Of the
studies reporting clinical data, this was generally either a symptom
questionnaire administered to participants or examination of
lesions. Two studies utilised either a leishmanin skin test [20] or
microscopic examination of skin scrapings from an active lesion
[21].
Random effects meta-analysis of the efficacy of ITNs was
conducted on data from four studies conducted in Iran (2 studies),
Afghanistan and Colombia [17–20] (Figure 2, Table 1). Pre-
intervention incidence of cutaneous leishmaniasis was comparable
in intervention and control groups in the three studies that
reported this data, with 95% confidence intervals for the risk ratio
crossing the null value. Random effect meta-analysis indicated a
PE of ITNs against cutaneous leishmaniasis of 77% (95% CI:
39%–91%, P= 0.003). Clinical data from one study in Turkey
[15] was not suitable for meta-analysis because this study did not
report numbers of cases or population at risk. Alten et al. reported
a significant reduction in incidence of cutaneous leishmaniasis in
Figure 1. Flowchart of study inclusion (adapted from [11]).
doi:10.1371/journal.pntd.0003228.g001
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ITN clusters, while incidence in control areas either stayed the
same or increased. However, this study was deemed to be at high
risk of bias and low quality.
Studies assessing the efficacy of ITNs reported mixed results
in terms of effect on sandfly density ranging from a relative
increase of 49% to a relative reduction of 96% (Table 2). Although
Emami et al. reported a highly significant PE against cutaneous
leishmaniasis in Iran, no effect on the mean number of
Phlebotomus sergenti captured per month was detected in this
study [17]. Similarly, Alten et al. reported a beneficial effect of
ITNs on clinical disease in Turkey and a percentage increase in
vector density relative to the control group was documented [15].
Three studies conducted in Colombia, Venezuela and Burkina
Faso assessed the efficacy of ITCs against cutaneous leishmaniasis
[16,22,23]. Two studies reported entomological data while one
reported both clinical and entomological data. Kroeger et al.
demonstrated a high PE against cutaneous leishmaniasis of 93%
(95% CI: 216%–100%, p= 0.06) in Venezuela (Table 1) [22].
Studies that measured the entomological effect of ITCs demon-
strated a high percentage reduction in vector density of 54%, 87%
and 98% (Table 2). However, the 98% reduction was observed in
a study that was deemed to be of low quality due to the study
design employed (non-randomised pre-post design), few sampling
sites for entomological data and short period of follow up.
A study which assessed the efficacy of ITCs and ITS against
cutaneous leishmaniasis in Iran reported a PE of 16% (95% CI:
2%–28%, p= 0.03) [21]. This study was deemed to be of low
quality due to the study design (non-randomised pre-post design)
and high risk of bias.
Efficacy of ITNs against visceral leishmaniasis
Three studies assessing the efficacy of ITNs on visceral
leishmaniasis were identified [24–27]. Two studies reported only
entomological data and one reported both clinical and entomo-
logical data. The Picado et al. study [27] did not show a significant
effect on incident Leishmania donovani infections (PE: 0.3%,
95%CI: 215%–14%, p= 0.97) or incident cases of visceral
leishmaniasis (PE: 4%, 95%CI: 281%–48%, p= 0.9) in India
and Nepal (Table 1). The same study, however, did appear to
show an effect on vector density with a relative reduction in the
mean number of P. argentipes females per light trap night of 57%
[26] (Table 3). Two studies conducted in Sudan [24] and
Bangladesh, India and Nepal [25] demonstrated a 100% and
35% (95% CI: 256% to 75%) reduction in vector density,
respectively (Table 3).
No studies were identified which assessed the efficacy of ITCs or
ITS against visceral leishmaniasis.
Efficacy of ITNs and ITCs against lymphatic filariasis
Two studies assessing the efficacy of ITNs against lymphatic
filariasis were identified, both of which collected entomological
data only [28,29]. ITNs generally were associated with a high level
of protection against Anopheles species, with approximately a 98%
reduction in vector density in the two studies conducted in Kenya
and Papua New Guinea (Table 4). Bøgh et al. reported a lower
percentage reduction in Culex quinquefasciatus density of 16%
[28].
One study conducted in India assessing the efficacy of ITCs
hung in eaves and doorways against lymphatic filariasis vectors
was identified [30]. Poopathi et al. detected an 82% reduction in
man biting density and a 79% reduction in indoor resting density
of Cx. quinquefasciatus [30] (Table 3). However, this study was
deemed to be of low quality mainly due to the study design
employed (non-randomised pre-post design), few sampling sites for
entomological data and short period of follow up.
Efficacy of ITNs, ITCs and ITS against dengue
One study conducted in Haiti assessed the efficacy of ITNs
against dengue [31]. Based on the five month post-intervention
survey this study showed that ITN use was associated with a 36%
Figure 2. Forest plot (random effects meta-analysis) indicating efficacy of ITNs against cutaneous leishmaniasis. The forest plot
displays post-intervention risk ratios and pre-intervention risk ratios separately to show comparability of groups at baseline.
doi:10.1371/journal.pntd.0003228.g002
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reduction in pupae per person and 77% reduction in indoor
ovitrap positivity. However, the study reported that ITNs were
associated with a 56% increase in house index, 143% increase in
container index, 60% increase in Breteau index and 20% increase
in outdoor ovitrap positivity. The bioassay results on new nets
from this study site indicated only 30% mortality of A. aegypti
suggesting that insecticide resistance may have been a problem.
Three studies were identified that assessed the efficacy of ITCs
against dengue vectors [32–34]. Kroeger et al. demonstrated in
Mexico a beneficial effect of ITCs on house index (25% reduction)
and pupae per person (39% reduction), but reported a relative
increase in Breteau index of 10% based on the 12 month follow up
survey [32]. The authors, however, reported a community-level
effect of the ITCs which meant that benefits in terms of reductions
in mosquito populations spilt over into control areas. They
postulate that this is why there is no significant difference between
intervention and control arms. Breteau and house indices from an
external control area closely follow seasonal rainfall patterns and
do not show similar reductions as in the study intervention and
control areas. In Thailand Lenhart et al. did not detect a beneficial
effect of ITCs on house index, container index, Breteau index or
pupae per person, with relative increases of 15%, 20%, 3% and
37%, respectively at the nine-month time point [33]. ITCs did,
however, show a beneficial effect on indoor and outdoor
oviposition rates with reductions of 44% and 49% in mean
numbers of eggs per trap, respectively at the six month time point,
although no significant difference between control and ITC arms
was reported at three or nine months. Another study in Thailand
where houses generally had a more closed design reported a 56%
reduction in house index, 67% reduction in Breteau index and
63% reduction in pupae per person index six months after the start
of the intervention [34]. At the 6-month follow up survey 71% of
households had at least one ITC. However, at the 18-month follow
up survey when ITC coverage had fallen to only 33% a much
lower effect on entomological parameters was observed (26%
reduction in house index, 8% reduction in Breteau index and
111% increase in pupae per person index).
A study of ITS reported a beneficial effect on both house index
and density index (adult Ae. aegypti) in Vietnam. In the
intervention arm both house and density index were reduced to
zero one month after installation of the screening and remained at
zero for the duration of the epidemic season (eight months post
intervention), compared to the control arm in which seasonal
peaks in both indices were observed [35,36]. The same study also
reported a PE of ITS against IgM seropositivity of 80% (95% CI:
53–92%, p,0.001) compared to the control group (Table 1). This
study used a non-randomised pre-post design and was deemed to
be of low quality.
Efficacy of ITNs against Japanese encephalitis
A single study by Dutta et al. assessed the efficacy of ITNs
against Japanese encephalitis vectors and seroconversion in India
[37]. This study was deemed to be of low quality due to the study
design employed (non-randomised pre-post design) and low
number of sampling sites for entomological data. No effect of
ITNs on mean density of adults of the Cx. vishnui group was
observed (reduction of 23.5%). The risk of seroconversion against
Japanese encephalitis virus was comparable across groups at
baseline, but the risk was significantly lower in the ITN group
compared to the control during the two year post intervention
period (PE: 67%, 95%CI: 44–80%, p,0.001) (Table 1).
Discussion
Our review shows the potential for ITNs, ITCs and ITS to
reduce vector borne diseases. Of particular note is the evidence on
high protective efficacy of ITNs against cutaneous leishmaniasis,
which suggests that there may be considerable collateral benefits of
ITN roll out where cutaneous leishmaniasis and malaria are co-
endemic. There is also good evidence of the efficacy of ITC and
Table 1. Effect of ITNs, ITCs and ITS against vector borne diseases.
Disease Intervention Study
Unadjusted PE
(95% CI, p value)
Adjusted PE
(95% CI, p value) Covariates adjusted for
Cutaneous leishmaniasis ITN Emami 2009 98% (93%, 100%, p,0.001) NR NR
Nadim 1995 50% (23%, 76%, p = 0.06) NR NR
Reyburn 2000 66% (54%, 75%, p,0.001) 69% (45%, 82%,
p,0.001)
Intra-household clustering
Rojas 2006 55% (6%, 79%, p = 0.03) 55% (214%, 82%) Age, residence located on the
periphery, roof of thatch, distance to
the forest ,50 m, community
participation score and prevalence
of infection in children ,5 years old
Alten 2003 37% NR NR
ITC Kroeger 2002 93% (216%, 100%, p = 0.06) NR NR
ITC and ITS Noazin 2013* 16% (2%, 28%, p = 0.03) NR NR
Visceral leishmaniasis ITN Picado 2010 Cases: 4% (281%, 48%,
p = 0.9) Infection: 0.3%
(215%, 14%, p = 0.97)
Cases: 215%
(2116%, 39%,
p = 0.64) Infection: 11%
(264%, 52%, p = 0.68)
Clustering, age group, sex, times
sprayed, and socioeconomic status.
Dengue ITS Nguyen 1996
Igarashi 1997
81% (53%, 92%, p,0.001) NR NR
Japanese encephalitis ITN Dutta 2011 67% (44%, 80%, p,0.001) NR NR
*study reported rates only, PE = protective efficacy, CI = confidence interval, NR = not recorded, More detail on cases and denominators given in Supporting
Information S10.
doi:10.1371/journal.pntd.0003228.t001
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ITS against cutaneous leishmaniasis. Weaker evidence exists for
the effect of ITS on dengue and ITNs on Japanese encephalitis,
but these interventions look promising. Further studies should be
conducted to confirm these findings. The potential of ITNs,
ITCs and ITS against Chagas disease, human African trypano-
somiasis and onchocerciasis remains untested. In several studies
the pattern of reduction in disease incidence was not matched by
reductions in entomological parameters. This is not unsurprising
given the complicated relationship between vector density and
risk of human infection, particularly when vector infection rate is
not taken into account.
Meta-analysis showed that ITNs were able to reduce the
incidence of cutaneous leishmaniasis by 77%. This finding
provides support for WHO’s recommendation that ITNs should
be used as a vector control method against this disease [38]. This
level of protective efficacy compares favourably with the 50%
protective efficacy of ITNs against P. falciparum malaria shown
by Lengeler [3]. Based on maps of cutaneous leishmaniasis [39]
and P. falciparum endemicity [40] there are large areas,
particularly in South America, where these diseases are likely
to be co-endemic. Non-malaria endemic countries where
cutaneous leishmaniasis is prevalent should consider rolling out
ITNs as part of control efforts. Similar reductions in vector
density were not observed which may be due to the ecology of
the vector species or differences in collection techniques. For
example studies by Alten et al. and Emami et al. sampled both
endophilic and exophilic species [15,17]. Studies by Kroeger et
al. [22] and Noazin et al. [21] reported significant effects of ITC
and ITC/ITS on clinical outcomes.
Clinical evidence from one study suggested that ITNs were
not effective against visceral leishmaniasis [27]. However, in this
study Picado et al. suggested that L. donovani transmission may
have been occurring outside the home where ITNs would have
little impact on preventing sandfly-human contact. In Africa
observational studies led to mixed results – several studies have
shown treated bednets to be protective against visceral
leishmaniasis [41,42], while others have shown no effect of
ITNs on L. donovani infection rate in P. orientalis, although the
number of infected P. orientalis identified was small in all
villages [43]. In south Asia, several observational studies have
shown use of (untreated) bednets to be protective against visceral
leishmaniasis [44,45].
The efficacy of ITNs in preventing leishmaniasis transmission
is dependent on a number of key variables related to vector
biology, type of nets and human behaviour. Studies have shown
protection is dependent on mesh size of the nets – nets designed
to be cooler which have large holes are more likely to let
sandflies though, even if they are insecticide treated [46]. ITNs
are likely to be more effective where sandflies bite indoors at
night and where people use ITNs consistently [47,48]. ITCs and
ITS may be advantageous over ITNs because these interventions
are in place all the time and since there is no need to set them up
at night compliance is less of an issue [21]. In general, where
transmission is occurring inside the home or where vectors rest
indoors, we would expect ITNs, ITCs or ITS to have a beneficial
effect, irrespective of whether the vectors are transmitting
cutaneous or visceral leishmaniasis. It is important to have a
sound grasp of sandfly biology and human behaviour in a
particular setting in order to understand where transmission is
occurring or where vectors rest before planning specific
intervention strategies.
There were no studies that met the selection criteria, which
reported the efficacy of ITNs against lymphatic filariasis
infection. In much of SSA and parts of the western Pacific,
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Anopheles mosquitoes transmit both lymphatic filariasis and
malaria and so theoretically ITNs should have a beneficial effect
on both diseases [49]. Observational studies have shown a
beneficial effect of ITNs on lymphatic filariasis transmission where
the disease is transmitted by Anopheles mosquitoes [50–53] and
ITNs may be particularly useful in areas co-endemic for lymphatic
filariasis and Loa Loa where mass drug administration of
ivermectin is contraindicated due to serious adverse events [54].
However, to our knowledge no randomised controlled trials have
been performed in these settings. Such a study would need to be of
long duration to show a reduction in microfilaraemia given that
adult worms have lifespans of between four and 10 years [55,56].
Alternatively, a study could use incidence of new infections in
young children as an outcome [57]. The efficacy of ITNs, ITCs
and ITS against Culex vectors of lymphatic filariasis, which are
predominant in urban areas [58], needs further assessment. Bøgh
et al. reported a 16% reduction in indoor resting density of Cx.
quinquefasciatus compared to a 98% reduction in Anopheles
species [28], presumably because Culex are less susceptible than
Anopheles to pyrethroids [59–61]. Another explanation may be
that transient reductions in vector density are masked because
Culex populations are massive and the population can rapidly
replace itself or immigrate. Poopathi et al. assessed the effect of
insecticide-treated eave and door curtains and reported an 82%
reduction in human biting density of Cx. quinquefasciatus [30]. It
may be the door curtain component of this intervention which is of
greatest importance given the findings of a study by Njie et al. who
reported that culicines enter houses via the door rather than the
eaves [62].
There is an increasing focus on intradomicile vector control for
dengue [63] because Ae. aegypti rest, feed, mate and reproduce
inside houses [64]. Targeting adult Ae. aegypti shifts the age
structure of the vector population to younger mosquitoes, which is
likely to have a large effect on human infections due to the
relatively long extrinsic incubation period of the dengue virus in
the mosquito [65]. However, since transmission of dengue occurs
mostly during the daytime the use of bednets has rarely been
considered as an intra-domiciliary control strategy. Studies
identified in this review reporting an effect of ITCs and ITS on
Ae. aegypti infestation levels [32,34–36] suggest that vectors are
coming into contact with these interventions indoors. The
likelihood of the vector coming into contact with the ITN, ITC
or ITS will depend on a number of factors including the size of the
home and construction. For example, Lenhart et al. state that the
open construction of the homes in their study conducted in
Thailand may explain why ITCs did not show any effect [33]. It is
generally recognised that greater coverage of the intervention will
result in mass killing, reduced vector survival and greater
reductions in transmission; i.e. a community level effect. This
was apparent in two of the dengue studies included in this review.
In one study use of ITCs in intervention areas led to a community
level effect whereby larval indices were reduced in neighbouring
control areas [32]. A study by Vanlerberghe reported that a
reduction in ITC coverage over time led to a reduced effect on
entomological parameters [34]. A similar pattern of coverage
dependent effects of ITCs on Ae. aegypti larval and pupal/
demographic indices was reported in another study in Venezuela,
which suggested that at least 50% coverage of ITCs was necessary
to reduce Ae. aegypti infestation levels by 50% [66].
Entomological data from studies on the efficacy of ITCs and
ITNs against the dengue vector Ae. aegypti were inconsistent
across the different indices measured. Focks and others have
questioned the reliability and sensitivity of traditional immature
aegypti indices (the house, container, and Breteau indices) and
there is growing consensus that these indices are of little value in
predicting risk of human infection [67]. Ovitraps are also not
recommended for assessing vector abundance because measures
are often biased by competition from natural oviposition sites [63].
Instead pupal/demographic indices (for example pupae per
person) are a better proxy for adult vector abundance or
measurement of adult vector density itself [67,68] and are more
appropriate for assessing transmission risk and directing control
operations [69,70]. The ideal would be to have a measure similar
to the entomological inoculation rate for malaria transmission
(incorporating both adult density and infection rate). However,
adult Ae. aegypti are difficult to catch in appreciable numbers
(though this is likely to improve with development of new adult
monitoring tools) and only small proportion of adults are infected
so it is difficult to detect infection [71].
The absence of studies of the two human trypanosome vectors
and black flies is noteworthy. For black flies and tsetse flies, the
predominantly outdoor exposure may be the main underlying
reason. For triatomines, the absence of intensive bednet campaigns
in Chagas disease endemic areas (which are often non-malarious,
especially for the main vector Triatoma infestans), and the general
lack of attention to improved housing may be among the principal
underlying factors for the lack of studies.
Our review has several limitations that should be noted. We
focused on a number of important neglected tropical diseases. This
group of diseases is well-named because few studies were
identified, despite conducting a comprehensive database search
and contacting disease experts. We also relaxed the inclusion
criteria somewhat in terms of study designs to include non-
randomised studies with pre- and post-intervention data. We did
not, however, do a full search of the grey literature which may
mean that publication bias was introduced resulting in over-
reporting of studies demonstrating that ITNs, ITCs and ITS were
protective. We did not request further information from authors if
reporting of methods or results was unclear in the published paper.
Due to the few studies identified, summary estimates could only be
generated using meta-analysis for cutaneous leishmaniasis. Studies
were generally at low risk of bias but were of mixed quality. The
main problems identified were with study design; e.g. short periods
of follow up and incomplete reporting in the published papers; e.g.
the method of sequence generation for randomisation was not
reported. We took a cautious approach and did not calculate
confidence intervals for entomological outcomes. This was due to
i) heterogeneity in study designs e.g. differences in follow up
periods pre- and post-intervention and between studies, studies
involving single houses and entomological parameters measured
once versus studies with multiple clusters and measurements over
an extended time period and ii) incomplete reporting in the
published papers e.g. confidence intervals and standard deviations
omitted. Without knowing the uncertainty around percentage
reductions it was not possible to make any conclusions regarding
the entomological effect of interventions. Improved reporting of
entomological data in studies and standardisation of study design
and conduct should be a priority. Entomological data should
always be assessed in combination with a clinical outcome where
possible, and clinical outcomes with standardised diagnostic
techniques and case definitions should remain the gold standard
outcome for assessing the efficacy of vector control interventions.
Less than half of the studies we considered reported the results
of bioassays for efficacy of the insecticide used. In one of the
studies conducted in Haiti there was some indication of resistance
[31]. However, many of the studies were conducted prior to the
early 2000s before the advent of pyrethroid resistance [72],
including those against cutaneous leishmaniasis that show a high
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PE. It is not possible, therefore, to say whether this level of efficacy
would be observed today. Currently pyrethroids are the only class
of insecticides suitable for use on LLINs and increasing coverage
of pyrethroid treated materials to control multiple VBD is likely to
increase selection pressure for development of resistance. Indeed,
pyrethroid resistance has been detected in a number of non-
malaria vectors including Cx. quinquefasciatus [73–75], sand flies
[76], Ae. aegypti and Ae. albopictus [77]. Even if pyrethroid
resistance increases it is likely that ITNs, ITC and ITS will still
afford some level of protection against vectors due to a barrier
effect. However, it would be sound to use insecticide treated
materials as part of an IVM strategy including other vector control
tools that do not rely on insecticide such as larval source
management or make sure that different insecticide classes are
used for IRS/fogging etc (if appropriate). In the meantime, new
types of insecticide treated materials, for example LLINs
impregnated with insecticides with two different modes of action,
are being developed which are showing promise against insecticide
resistant malaria vectors [78,79].
In terms of collateral benefits there may also be beneficial effects
of ITNs, curtains and screening on preventing household pests
such as bedbugs, headlice, cockroaches and rodents which
although not systematically assessed in this review are important
benefits which increase acceptability and encourage compliance
with interventions [80–82].
In conclusion, ITNs, ITCs and ITS have great potential to
reduce VBDs. The biological insight that follows from this
conclusion is that a substantial proportion of the vector
population must be resting or feeding indoors. Evidence on
efficacy of ITNs, ITC and ITS against multiple VBDs should be
paired with maps of disease co-endemicity in order to prioritise
and focus resources to areas of greatest disease burden. The use
of interventions against multiple diseases has the potential to
reduce costs and make better use of financial and human
resources. This requires functional coordination between disease-
specific programmes on planning, implementation and monitor-
ing and evaluation with sharing of existing infrastructure and
competencies. Beneficial effects on multiple VBDs will serve to
increase the cost effectiveness of insecticide-treated materials and
this may help to bolster the case for vector control funding. This
review demonstrates some promising results, but highlights the
urgent need for further well conducted studies. The efficacy of
ITNs, ITCs and ITS against VBDs needs to be rigorously tested
in randomised controlled trials with standardised clinical
outcomes.
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